Prenatal Diagnosis for Primary Immunodeficiency Disorders-An Overview of the Indian Scenario.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 30 09 2020
accepted: 04 11 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 24 6 2021
Statut: epublish

Résumé

Prenatal Diagnosis (PND) forms an important part of primary preventive management for families having a child affected with primary immunodeficiency. Although individually sparse, collectively this group of genetic disorders represents a significant burden of disease. This paper discusses the prenatal services available for affected families at various centers across the country and the challenges and ethical considerations associated with genetic counseling. Mutation detection in the index case and analysis of chorionic villous sampling or amniocentesis remain the preferred procedures for PND and phenotypic analysis of cordocentesis sample is reserved for families with well-characterized index case seeking PND in the latter part of the second trimester of pregnancy. A total of 112 families were provided PND services in the last decade and the presence of an affected fetus was confirmed in 32 families. Post-test genetic counseling enabled the affected families to make an informed decision about the current pregnancy.

Identifiants

pubmed: 33365035
doi: 10.3389/fimmu.2020.612316
pmc: PMC7750517
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

612316

Informations de copyright

Copyright © 2020 Yadav, Gupta, Dalvi, Bargir, Hule, Shabrish, Aluri, Kulkarni, Kambli, Uppuluri, Seshadri, Jagadeesh, Suresh, Raja, Taur, Malaischamy, Ghosh, Mahalingam, Kadam, Lashkari, Tamhankar, Tamhankar, Mithbawkar, Bhattad, Jhawar, Makam, Bansal, Prasad, Govindaraj, Guhan, Bharadwaj Tallapaka, Desai, Raj and Madkaikar.

Déclaration de conflit d'intérêts

SMal, PG, SMah, and PKad were employed by the company MedGenome Labs Private Limited. SJ, BS, and JR were employed by the company Mediscan Systems. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Expert Rev Mol Diagn. 2018 Aug;18(8):689-699
pubmed: 29962246
J Clin Immunol. 2019 Feb;39(2):182-187
pubmed: 30778805
Genet Med. 2018 Aug;20(8):791-799
pubmed: 30032162
West J Med. 1993 Sep;159(3):391-5
pubmed: 8236982
J Clin Immunol. 2014 Apr;34(3):316-22
pubmed: 24535004
Prenat Diagn. 2018 Nov;38(12):897-903
pubmed: 30171820
Indian J Psychiatry. 2009 Jan;51(1):3-5
pubmed: 19742202
Clin Chem Lab Med. 2013 Jan;51(1):197-204
pubmed: 23072857
Indian J Pediatr. 2012 Dec;79(12):1605-9
pubmed: 22477041
Clin Mol Allergy. 2008 Jun 02;6:5
pubmed: 18518992
Per Med. 2015;12(3):283-295
pubmed: 26478737
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
Ultrasound Obstet Gynecol. 2019 Oct;54(4):442-451
pubmed: 31124209
Indian J Med Res. 2011 Oct;134:552-60
pubmed: 22089620
J Clin Immunol. 2018 Aug;38(6):646-655
pubmed: 30046960
Genet Mol Res. 2015 Dec 22;14(4):18078-89
pubmed: 26782455
Ultrasound Obstet Gynecol. 2016 Aug;48(2):256-68
pubmed: 27485589
Med Health Care Philos. 2017 Jun;20(2):195-205
pubmed: 27631408

Auteurs

Reetika Malik Yadav (RM)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Maya Gupta (M)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Aparna Dalvi (A)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Umair Ahmed Bargir (UA)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Gouri Hule (G)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Snehal Shabrish (S)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Jahnavi Aluri (J)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Manasi Kulkarni (M)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Priyanka Kambli (P)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Ramya Uppuluri (R)

Department of Pediatric Hematology-Oncology, Blood Marrow Transplantation, Apollo Hospitals, Chennai, India.

Suresh Seshadri (S)

Department of Clinical Genetics & Genetic Counseling, Mediscan Systems, Chennai, India.

Sujatha Jagadeesh (S)

Department of Clinical Genetics & Genetic Counseling, Mediscan Systems, Chennai, India.

Beena Suresh (B)

Department of Clinical Genetics & Genetic Counseling, Mediscan Systems, Chennai, India.

Jayarekha Raja (J)

Department of Clinical Genetics & Genetic Counseling, Mediscan Systems, Chennai, India.

Prasad Taur (P)

Department of Immunology and Department of Pediatric Hemato-Oncology, Bai Jerbai Wadia Hospital for Children, Mumbai, India.

Sivasankar Malaischamy (S)

MedGenome Labs Private Limited, Bangalore, India.

Priyanka Ghosh (P)

MedGenome Labs Private Limited, Bangalore, India.

Shweta Mahalingam (S)

MedGenome Labs Private Limited, Bangalore, India.

Priya Kadam (P)

MedGenome Labs Private Limited, Bangalore, India.

Harsha Prasada Lashkari (HP)

Department of Pediatrics, Kasturba Medical College Hospital, Manipal Academy of Higher Education, Mangalore, India.

Parag Tamhankar (P)

Centre for Medical Genetics, Mumbai, India.

Vasundhara Tamhankar (V)

Centre for Medical Genetics, Mumbai, India.

Shilpa Mithbawkar (S)

Centre for Medical Genetics, Mumbai, India.

Sagar Bhattad (S)

Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Aster CMI Hospital, Bangalore, India.

Prerna Jhawar (P)

Department of Fetal Medicine, Motherhood Hospital, Bangalore, India.

Adinarayan Makam (A)

Department of Fetal Medicine, Adi Advanced Centre for Fetal Care, Bangalore, India.

Vandana Bansal (V)

Fetal Medicine Department Surya Hospitals, Mumbai, India.

Malathi Prasad (M)

Fetal Medicine Centre, Trichy, India.

Geeta Govindaraj (G)

Department of Pediatrics, Government Medical College, Kozhikode, Calicut, India.

Beena Guhan (B)

Department of Pediatrics, Government Medical College, Kozhikode, Calicut, India.

Karthik Bharadwaj Tallapaka (K)

CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.

Mukesh Desai (M)

Department of Immunology and Department of Pediatric Hemato-Oncology, Bai Jerbai Wadia Hospital for Children, Mumbai, India.

Revathi Raj (R)

Department of Pediatric Hematology-Oncology, Blood Marrow Transplantation, Apollo Hospitals, Chennai, India.

Manisha Rajan Madkaikar (MR)

Center of Excellence for PIDs, Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH